JAPANESE B ENCEPHALITIS VIRUS: ITS DIFFERENTIATION FROM ST. LOUIS ENCEPHALITIS VIRUS AND RELATIONSHIP TO LOUPING-ILL VIRUS.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 17832643)

Published in Science on October 29, 1937

Authors

L T Webster

Articles citing this

RNA virus reverse genetics and vaccine design. Viruses (2014) 0.82

Articles by these authors

A VIRUS ENCOUNTERED IN THE STUDY OF MATERIAL FROM CASES OF ENCEPHALITIS N THE ST. LOUIS AND KANSAS CITY EPIDEMICS OF 1933. Science (1933) 6.93

NUTRITION OF THE HOST AND NATURAL RESISTANCE TO INFECTION : I. THE EFFECT OF DIET ON THE RESPONSE OF SEVERAL GENOTYPES OF MUS MUSCULUS TO SALMONELLA ENTERITIDIS INFECTION. J Exp Med (1945) 3.52

ISOLATION OF POLIOMYELITIS VIRUS FROM THE NASOPHARYNX. J Exp Med (1935) 3.14

RECOVERY OF EASTERN EQUINE ENCEPHALOMYELITIS VIRUS FROM BRAIN TISSUE OF HUMAN CASES OF ENCEPHALITIS IN MASSACHUSETTS. Science (1938) 2.88

ST. LOUIS ENCEPHALITIS. Science (1934) 2.80

ANTIRABIC IMMUNIZATION WITH CULTURE VIRUS RENDERED AVIRULENT BY ULTRA-VIOLET LIGHT. Science (1937) 2.59

Diagnostic and Immunological Tests of Rabies in Mice. Am J Public Health Nations Health (1936) 2.56

Experiments on Antirabic Vaccination With Tissue Culture Virus. Am J Public Health Nations Health (1938) 2.13

An Improved Non-Virulent Rabies Vaccine. Am J Public Health Nations Health (1942) 1.80

CHARACTERISTICS OF A STRAIN OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS ENCOUNTERED AS A CONTAMINANT IN TISSUE CULTURES OF RABIES VIRUS. J Exp Med (1940) 1.69

GIANT CELLS IN CULTURES FROM HUMAN LYMPH NODES. J Exp Med (1921) 1.63

MIGRATION OF LYMPHOCYTES IN PLASMA CULTURES OF HUMAN LYMPH NODES. J Exp Med (1921) 1.58

PROPAGATION OF RABIES VIRUS IN TISSUE CULTURE AND THE SUCCESSFUL USE OF CULTURE VIRUS AS AN ANTIRABIC VACCINE. Science (1936) 1.57

AN IRRADIATED NON-VIRULENT ANTIRABIES VACCINE. Science (1940) 1.42

Benzoyl and hydroxybenzoyl esters of coenzyme A. Ultraviolet characterization and reaction mechanisms. J Biol Chem (1974) 1.40

THE USE OF ULTRAVIOLET LIGHT IN PREPARING A NON-VIRULENT ANTIRABIES VACCINE. J Exp Med (1940) 1.39

Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity. J Immunol (1975) 1.27

Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J Infect Dis (1985) 1.25

CLOSE RELATION BETWEEN RUSSIAN SPRING-SUMMER ENCEPHALITIS AND LOUPING-ILL VIRUSES. Science (1943) 1.25

Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med (1975) 1.18

RELATION BETWEEN DEGREE OF IMMUNITY OF MICE FOLLOWING VACCINATION WITH ST. LOUIS ENCEPHALITIS VIRUS AND THE TITRE OF THE PROTECTIVE ANTIBODIES OF THE SERUM. J Exp Med (1938) 1.18

Studies of the acetyl coenzyme A synthetase reaction. II. Crystalline acetyl coenzyme A synthetase. J Biol Chem (1965) 1.13

EPIDEMIOLOGICAL STUDIES ON RESPIRATORY INFECTIONS OF THE RABBIT : VI. ETIOLOGY OF OTITIS MEDIA. J Exp Med (1925) 1.12

Identification of separate acyl- CoA:glycine and acyl-CoA:L-glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man. J Biol Chem (1976) 1.01

Evidence for a medium-chain fatty acid: coenzyme A ligase (adenosine monophosphate) that activates salicylate. Mol Pharmacol (1971) 1.01

Enzymatic conversion of salicylate to salicylurate. Mol Pharmacol (1971) 0.99

Benzoyl and hydroxybenzoyl esters of coenzyme A. Purification and nuclear magnetic resonance characterization; conformation in solution. J Biol Chem (1974) 0.98

Benzoyl-coenzyme A:glycine N-acyltransferase and phenylacetyl-coenzyme A:glycine N-acyltransferase from bovine liver mitochondria. Purification and characterization. J Biol Chem (1979) 0.96

Studies of the acetyl coenzyme A synthetase reaction. IV. The requirement for monovalent cations. J Biol Chem (1966) 0.95

Studies of the acetyl coenzyme A synthetase reaction. V. The requirement for monovalent and divalent cations in partial reactions involving enzyme-bound acetyl adenylate. J Biol Chem (1967) 0.92

Reductive metabolism of niridazole by adult Schistosoma mansoni. Correlation with covalent drug binding to parasite macromolecules. Mol Pharmacol (1983) 0.92

Relative importance of bacterial and mammalian nitroreductases for niridazole mutagenesis. Cancer Res (1980) 0.91

ENZYMATIC FORMATION OF ADENYL TRYPTOPHAN: ISOLATION AND IDENTIFICATION. Proc Natl Acad Sci U S A (1958) 0.91

Studies of the acetyl coenzyme A synthetase reaction. 3. Evidence of a double requirement for divalent cations. J Biol Chem (1965) 0.87

The molecular weight and thiol residues of acetyl-coenzyme A synthetase from ox heart mitochondria. Biochem J (1973) 0.87

Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide. Clin Pharmacol Ther (1975) 0.84

Equilibrium constants of the reactions of acetyl coenzyme A synthetase and the hydrolysis of adenosine triphosphate to adenosine monophosphate and inorganic pyrophosphate. J Biol Chem (1974) 0.83

Concentration-time course of niridazole and six metabolites in the serum of four Filipinos with Schistosoma japonicum infection. J Pharmacol Exp Ther (1984) 0.83

Studies on the importance of lecithin for cholesterol solubilization in bile. J Lab Clin Med (1966) 0.81

Identification and purification of immunosuppressive activity in the urine of rats and a human patient treated with niridazole. J Immunol (1977) 0.80

Praziquantel-induced vesicle formation in the tegument of male Schistosoma mansoni is calcium dependent. J Parasitol (1984) 0.77

RELATIONSHIP OF THE VIRUS OF LOUPING ILL IN SHEEP AND THE VIRUS OF RUSSIAN SPRING-SUMMER ENCEPHALITIS IN MAN. J Exp Med (1944) 0.76

WANDERING CELLS, ENDOTHELIAL CELLS, AND FIBROBLASTS IN CULTURES FROM HUMAN LYMPH NODES. J Exp Med (1921) 0.75

Concentration time course of praziquantel in Filipinos with mild Schistosoma japonicum infection. Southeast Asian J Trop Med Public Health (1994) 0.75

Antirabic Vaccination-Present Status. Am J Public Health Nations Health (1941) 0.75

Hepatic coma--a biochemical disorder of the brain. Gastroenterology (1965) 0.75

Isolation, characterization, and synthesis of an immunoregulatory metabolite of niridazole: 1-thiocarbamoyl-2-imidazolidinone. Mol Pharmacol (1980) 0.75

Effect of niridazole and niridazole immunoregulatory factor (NIF) on cutaneous delayed hypersensitivity in mice. Immunopharmacology (1979) 0.75

Aerobic metabolism of niridazole by rat liver microsomes. Mol Pharmacol (1979) 0.75

Further observations on the effects of 1-thiocarbamoyl-2-imidazolidinone (TCI) on cell-mediated immunity. Immunopharmacology (1982) 0.75

Suppression of cell-mediated immune responses in vivo and in vitro by 1-thiocarbamoyl-2-imidazolidinone. Immunopharmacology (1982) 0.75

EXPERIMENTAL EPIDEMIOLOGY. Science (1932) 0.75

1-thiocarbamoyl-2-imidazolidinone, a metabolite of niridazole in Schistosoma mansoni. Mol Biochem Parasitol (1984) 0.75

Recent Knowledge of Epidemic Diseases. Bull N Y Acad Med (1928) 0.75

Toxicogenetics of niridazole in inbred mice. J Pharmacol Exp Ther (1980) 0.75

Formation of N-(5-nitro-2-thiazolyl)-N'-carboxymethylurea from 5-hydroxyniridazole. Role of aldehyde dehydrogenase in the oxidative metabolism of niridazole. Drug Metab Dispos (1991) 0.75

The formation of 1-thiocarbamoyl-2-imidazolidinone from niridazole in mouse intestine. J Pharmacol Exp Ther (1981) 0.75

Quantitative determination of praziquantel in serum by high-performance liquid chromatography. J Chromatogr (1983) 0.75

Benzoyl-CoA: amino acid and phenylacetyl-CoA: amino acid N-acyltransferases. Methods Enzymol (1981) 0.75

Effect of 1-thiocarbamoyl-2-imidazolidinone on the generation of plaque forming cell responses. Int J Immunopharmacol (1985) 0.75

Niridazole suppression of experimental allergic encephalomyelitis in Lewis rats. J Immunol (1977) 0.75

4-Keto niridazole: a major niridazole metabolite with central nervous system toxicity different than niridazole. J Pharmacol Exp Ther (1984) 0.75

COMMITTEE OF THE NATIONAL RESEARCH COUNCIL ON THE MAINTENANCE OF PURE GENETIC STRAINS. Science (1943) 0.75

The preparation and characterization of mitochondria from developing red blood cells. J Lab Clin Med (1967) 0.75